Clinical Trial Update: A Study to Determine the Efficacy and Safety of Fasinumab for the Treatment of Adults With Chronic Low Back Pain [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on fasinumab for adults with chronic low back pain completed phases 2/3; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Fasinumab (fasinumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Low Back Pain | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-08-01